Skip to main content
Clinical Trials/ACTRN12608000225314
ACTRN12608000225314
Completed
Not Applicable

In intracytoplasmic sperm injection (ICSI) cases using long gonadotropin releasing hormone (GnRH) agonist protocol, does the use of vaginal etradiol luteal supplementation compared to oral estradiol supplementation or propgesterone alone improve luteal hormonal profile or pregnancy rate?

Eman Amin Elgindy0 sites270 target enrollmentMay 1, 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Infertility
Sponsor
Eman Amin Elgindy
Enrollment
270
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 1, 2008
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Eman Amin Elgindy

Eligibility Criteria

Inclusion Criteria

  • Women undergoing intracytoplasmic sperm injection due to male factor of infertility using pituitary desensitization by GnRH agonist long protocol

Exclusion Criteria

  • Age \> 37 years, body mass index (BMI) \< 18 or \> 29, irregular menstral cycles, women with single ovary, day 3 serum follicle stimulating hormone (FSH) 9\.5 milli international units (mIU)/ml or more, basal antral follicle count 6 or less, 5 or less retreived mature follicles, non availability of good quality embryos and failure to obtain a written consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials